These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [TBL] [Abstract][Full Text] [Related]
3. [Guarantee of drug quality for animal health and consumer protection]. Kroker R Dtsch Tierarztl Wochenschr; 1994 Jul; 101(7):278-80. PubMed ID: 7924965 [TBL] [Abstract][Full Text] [Related]
5. Marketing authorisation of fish drugs--current status and future intentions. Bernoth EM Zentralbl Veterinarmed B; 1990 Aug; 37(6):401-6. PubMed ID: 2402969 [TBL] [Abstract][Full Text] [Related]
6. Quality control of radiopharmaceuticals. Pfeiffer G Nuklearmedizin; 1984 Feb; 23(1):4-8. PubMed ID: 6728692 [TBL] [Abstract][Full Text] [Related]
7. [Effect of the Reorganization of Drug Legislation "Act" on the production and admission of infusion solutions]. Mohrbutter K; Schnieders B; Schuster J; Wolff U Klin Anasthesiol Intensivther; 1977; (14):74-88. PubMed ID: 926693 [No Abstract] [Full Text] [Related]
8. Indonesian parliament adopts strict anti-drug law. HIV AIDS Policy Law Rev; 2009 Dec; 14(2):27-8. PubMed ID: 20225510 [TBL] [Abstract][Full Text] [Related]
9. [The new narcotics law]. Becker W Ther Ggw; 1972 Oct; 111(10):1514-34. PubMed ID: 5087287 [No Abstract] [Full Text] [Related]
10. The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons. Schicke RK Int J Health Serv; 1973; 3(2):223-36. PubMed ID: 4197751 [No Abstract] [Full Text] [Related]
11. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials]. Dreier G; Marx C; Schmoor C; Maier-Lenz H Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256 [TBL] [Abstract][Full Text] [Related]
13. [Clinical trials for medicinal products. New European and national legal rules]. Kreutz G Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):524-9. PubMed ID: 15887061 [TBL] [Abstract][Full Text] [Related]
15. Drug dangers and reactions. WEILERSTEIN RW Calif Med; 1961 Jan; 94(1):9-11. PubMed ID: 13783849 [TBL] [Abstract][Full Text] [Related]
16. [Is drug therapy safer as a result of the drug legislation?]. Kimbel KH Internist (Berl); 1980 Jun; 21(6):306-10. PubMed ID: 7005166 [No Abstract] [Full Text] [Related]
17. New law in Germany compensates patients for drug side-effects. Orellana C Lancet; 2002 Aug; 360(9331):471. PubMed ID: 12241734 [No Abstract] [Full Text] [Related]
18. [The community clinical trial system EudraCT at the EMEA for the monitoring of clinical trials in Europe]. Krafft H Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):453-8. PubMed ID: 15830257 [TBL] [Abstract][Full Text] [Related]
19. [The influence of the drug legislation on drug information for the physician and patient]. Schwabe U Internist (Berl); 1980 Jun; 21(6):311-7. PubMed ID: 7005167 [No Abstract] [Full Text] [Related]
20. [Drug effectiveness in the framework of drug legislation and health insurance law]. Töns H Internist (Berl); 1980 Jun; 21(6):339-45. PubMed ID: 7005171 [No Abstract] [Full Text] [Related] [Next] [New Search]